UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 Or 15(D) of The
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 28, 2003
ANTARES PHARMA, INC.
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Minnesota 0-20945 41-1350192
---------------------------- ------------ -------------------
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation) File Number) Identification No.)
707 Eagleview Boulevard, Suite 414, Exton, PA 19341
-------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (610) 458-6200
Not Applicable
-------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events and Required FD Disclsoure.
On May 1, 2003, Antares Pharma, Inc. (the "Company") announced that the
Listing Qualifications arm of The Nasdaq Stock Market, Inc. had determined to
delist the Company's shares of common stock from trading on The Nasdaq SmallCap
Market effective May 7, 2003. The Company has requested an oral hearing with the
Listing Qualifications Panel to appeal Nasdaq's determination. This hearing
request will stay the delisting of the Company's common stock pending the
Panel's decision.
A copy of the press release issued by the Company on May 1, 2003 is
attached hereto as Exhibit 99.1
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
99.1 Press Release dated May 1, 2003.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: May 1, 2003 ANTARES PHARMA, INC.
By /s/ Lawrence M. Christian
---------------------------
Lawrence M. Christian
Chief Financial Officer
EXHIBIT INDEX
99.1 Press Release dated May 1, 2003.